For decades, cervical cancer has been called a preventable disease, yet the deaths continue at a relentless pace. Experts say the tools exist, but without investment in health systems, education, and equity, the clock will keep ticking, and five other women will die every ten minutes.

Every two minutes, a woman dies from cervical cancer somewhere in the world, according to the United Nations and World Health Organization, a staggering reminder that the disease remains one of the leading causes of cancer death among women.
Cervical cancer begins in the cervix, the lower part of the uterus, and is caused almost entirely by persistent infection with high-risk strains of the human papillomavirus, or HPV.
Worldwide, an estimated 660,000 women were diagnosed with the disease in 2022 and roughly 350,000 died, the World Health Organization reports.
The vast majority of deaths occur in low- and middle-income countries, where health systems struggle to provide vaccines, screening, and treatment.
“Every two minutes, a woman dies from cervical cancer, a disease that is both devastating and largely preventable,” said Dr. Sania Nishtar, chief executive officer of Gavi, the Vaccine Alliance.
She noted that tens of millions of girls have been vaccinated against HPV in lower-income countries, potentially preventing a million deaths.
Despite progress in some regions, structural barriers continue to block access to lifesaving interventions.
In Kenya, fewer than half of women have ever been screened, and access to treatment for pre-cancerous or cancerous lesions is limited.
Rural health facilities often lack basic equipment, and trained staff are in short supply. Patients must travel long distances to reach hospitals, and costs for tests and treatment can be prohibitive.
“In 2018, WHO issued a global call for action to eliminate cervical cancer,” said Dr. Tedros Adhanom Ghebreyesus, director-general of the World Health Organization. “But unless we build health systems that reach every girl and every woman, cervical cancer will continue to take lives unnecessarily.”
Public health experts point to the critical role of education and outreach.
Misconceptions about the HPV vaccine, fear of medical procedures, and social stigma surrounding cervical cancer prevent many women from seeking care.
In some communities, cultural taboos discourage open discussion about reproductive health, leaving women unaware of the risks or the availability of preventive services.
Even when vaccines and screening programs exist, delivery is uneven.
Vaccine supply chains are fragile in many low-income countries, and some governments struggle to fund national programs.
In 2021, only about 13 percent of girls globally had received the full course of the HPV vaccine, a significant drop from pre-pandemic levels.
“Vaccination alone is not enough,” said Dr. Chris Elias, president of global development at the Bill & Melinda Gates Foundation.
“We need to strengthen screening and treatment services, improve access, and address the social and economic barriers that prevent women from getting care.”
The disease also carries a heavy social and economic cost.
Cervical cancer primarily affects women in their 30s and 40s, many of whom are primary caregivers and breadwinners.
Losing a mother or caregiver has ripple effects on families, children, and communities.
International health leaders have set ambitious targets to eliminate cervical cancer as a public health problem by 2030.
The goals include vaccinating 90 percent of girls against HPV by age 15, screening 70 percent of women by ages 35 and 45, and ensuring that 90 percent of women diagnosed with cervical disease receive treatment.
Experts say meeting these targets will require sustained investment and political commitment.
Dr. Catherine Russell, executive director of UNICEF, emphasized the urgency. “The tools exist to prevent these deaths. What is missing is scale, equity, and the will to reach every girl and every woman,” she said.
For women and families affected, the statistics are deeply personal.
Many women in low-resource settings arrive at hospitals with advanced disease, too late for curative treatment. The challenge is not scientific but systemic.
Health advocates warn that without significant improvements in delivery and outreach, the toll of a woman dying every two minutes will continue.
Global health agencies are calling for renewed urgency.
They argue that with equitable access to vaccines, screening, and treatment, cervical cancer deaths can be dramatically reduced.
The question is whether the world is willing to invest in the systems and infrastructure necessary to reach the women most at risk.
Get the latest news and insights that are shaping the world. Subscribe to Impact Newswire to stay informed and be part of the global conversation.
Got a story to share? Pitch it to us at info@impactnews-wire.com and reach the right audience worldwide
Discover more from Impact AI News
Subscribe to get the latest posts sent to your email.


